Biomedical Engineering Reference
In-Depth Information
h
b
i
a
c
d
f
e
g
C
16
H
33
O
55
°
C
OH
C
16
H
33
N
O
C
16
H
33
O
e
45
°
C
i
O
13
c
b
N
O
g
C
16
H
33
HO
d
f
h
35
°
C
O
C
16
H
33
a
10
25
°
C
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
(a)
(b)
55
◦
C). Reprinted with permission from Ref.
[60b]. Copyright 2009 American Chemical
Society.
Figure 1.8
(a) Structure of gelator
10
.(b)
Variable temperature
1
H NMR spectra of 10
mg/ml
10
in C
6
D
6
in its gel phase (25 and
35
◦
C) and its solution/sol phase (45 and
H
(a)
i
H
i
H
H
g
O
H
N
O
H
a
c
H
f
I
H
O
N
N
e
H
m
H
O
O
b
H
d
11
H
c
(c)
(b)
100˚C
90˚C
80˚C
70˚C
60˚C
50˚C
48˚C
46˚C
44˚C
42˚C
40˚C
37˚C
35˚C
30˚C
25˚C
100˚C
90˚C
80˚C
70˚C
60˚C
50˚C
48˚C
46˚C
44˚C
42˚C
40˚C
37˚C
35˚C
30˚C
25˚C
H
H
a
H
CH
2
b
f
8
9
8
7
6
5
4
9
ppm
Figure 1.9
(a) Structure of leucine-based
gelator
11
. (b) Superimposition of 1 wt%
11
in toluene-
d
8
1
H NMR spectra at different
temperatures (diphenylmethane as internal
standard). (c) Change of signals from the
two H
c
protons upon heating (in the rect-
angle). Intensities are normalized. Reprinted
with permission from Ref. [61c]. Copyright
2010 American Chemical Society.
Search WWH ::
Custom Search